Cargando…

Agitation and impulsivity in mid and late life as possible risk markers for incident dementia

To identify knowledge gaps regarding new‐onset agitation and impulsivity prior to onset of cognitive impairment or dementia the International Society to Advance Alzheimer's Research and Treatment Neuropsychiatric Syndromes (NPS) Professional Interest Area conducted a scoping review. Extending a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bateman, Daniel R., Gill, Sascha, Hu, Sophie, Foster, Erin D., Ruthirakuhan, Myuri T., Sellek, Allis F., Mortby, Moyra E., Matušková, Veronika, Ng, Kok Pin, Tarawneh, Rawan M., Freund‐Levi, Yvonne, Kumar, Sanjeev, Gauthier, Serge, Rosenberg, Paul B., Ferreira de Oliveira, Fabricio, Devanand, D. P., Ballard, Clive, Ismail, Zahinoor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507499/ https://www.ncbi.nlm.nih.gov/pubmed/32995467 http://dx.doi.org/10.1002/trc2.12016

Ejemplares similares

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
por: Ruthirakuhan, Myuri T., et al.
Publicado: (2019)

Diagnostic criteria for apathy in neurocognitive disorders
por: Miller, David S., et al.
Publicado: (2021)

Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria
por: De Mauleon, Adelaide, et al.
Publicado: (2021)

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
por: Lanctôt, Krista L., et al.
Publicado: (2023)

Use of Physical and Intellectual Activities and Socialization in the Management of Cognitive Decline of Aging and in Dementia: A Review
por: Ruthirakuhan, Myuri, et al.
Publicado: (2012)

Depressive symptoms as a barrier to engagement in physical activity in older adults with and without Alzheimer’s disease
por: Watts, Amber S., et al.
Publicado: (2018)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
por: Ruthirakuhan, Myuri, et al.
Publicado: (2022)

Apathy as a determinant of health behaviors in older adults: Implications for dementia risk reduction
por: Harrison, Fleur, et al.
Publicado: (2023)

High “Normal” Blood Glucose Is Associated with Decreased Brain Volume and Cognitive Performance in the 60s: The PATH through Life Study
por: Mortby, Moyra E., et al.
Publicado: (2013)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions
por: Keszycki, Rachel M., et al.
Publicado: (2019)

Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults
por: Eramudugolla, Ranmalee, et al.
Publicado: (2017)

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
por: Fox, Chris, et al.
Publicado: (2012)

Relating Education, Brain Structure, and Cognition: The Role of Cardiovascular Disease Risk Factors
por: Mortby, Moyra E., et al.
Publicado: (2014)

On Agitation
Publicado: (1920)

Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
por: Cummings, Jeffrey, et al.
Publicado: (2015)

Cerebrospinal Fluid Markers of Synaptic Injury and Functional Connectivity in Alzheimer Disease: Protocol for a Cross-Sectional Study
por: Tarawneh, Rawan
Publicado: (2019)

Biomarkers: Our Path Towards a Cure for Alzheimer Disease
por: Tarawneh, Rawan
Publicado: (2020)

Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
por: Tarawneh, Rawan
Publicado: (2023)

The Fate of the Agitator
Publicado: (1918)

Microbial Ecology in Anaerobic Digestion at Agitated and Non-Agitated Conditions
por: Tian, Zhuoli, et al.
Publicado: (2014)

Changes in QTc Interval in the Citalopram for Agitation in Alzheimer's Disease (CitAD) Randomized Trial
por: Drye, Lea T., et al.
Publicado: (2014)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Agitation in the ICU: part one Anatomical and physiologic basis for the agitated state
por: Crippen, David
Publicado: (1999)

Institutionalization risk and costs associated with agitation in Alzheimer's disease
por: Cloutier, Martin, et al.
Publicado: (2019)

Matrons, and Nurse Agitators
Publicado: (1918)

Matrons, and Nurse Agitators
Publicado: (1918)

Anti-Tuberculosis Agitation
Publicado: (1907)

The Anti-vivisection Agitation
por: Wilcox, E. V.
Publicado: (1898)

The Anti-vivisection Agitation
por: Wilcox, E. V.
Publicado: (1898)

Agitated Psychiatric Patient
por: Pabst, Brooke M, et al.
Publicado: (2020)

What Is the Evidence for Using Anti-Epileptic Drugs to Treat Agitation and Irritability in Huntington's Disease?
por: Leong, Kok Keong, et al.
Publicado: (2022)

Neural correlates of the impulse dyscontrol domain of mild behavioral impairment
por: Gill, Sascha, et al.
Publicado: (2021)

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation
por: Akil, Ayman, et al.
Publicado: (2015)

Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20–76 years
por: Anstey, Kaarin J., et al.
Publicado: (2021)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

A data‐driven examination of apathy and depressive symptoms in dementia with independent replication
por: Vasconcelos Da Silva, Miguel, et al.
Publicado: (2023)

Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_50g989aqj6iq5f11thapl8vf71